Delivery Order SPE2DB22D2009-SPE2DB24FM0UJ

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1110|SPE2DB24FK31H, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a ceiling value of $2,916.67 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 20, 2024. The contract is not designated as a set-aside....
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $5,324.92 and a completion date of May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with identification number SPE2DB22D2103|SPE2DB24FR8NX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $7,378.20 and a completion date of November 22, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held...
This federal contract award, valued at $7,432.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of February 7, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAR53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,384.64 firm-fixed-price delivery order contract is for the provision of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of February 18, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with an ID of SPE2DB20D1004|SPE2DB25FNDDC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $3,177.32 and a completion date of December 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D1103|SPE2DB24FTKZ6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,377.19 delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. This award is not designated with a set-aside requirement, indicating open competition....
This federal contract award, with the ID SPE2DB20D2014|SPE2DB24FA89N, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $16,482.88 and a completion date of January 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 MG TABLET 60S. The contract has a ceiling value of $2,432.86 and is a firm fixed price delivery order with a completion date of March 19, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,451.56 firm fixed-price delivery order is for JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM0UJ
    Delivery Order

This federal contract award, identified as SPE2DB22D2009|SPE2DB24FM0UJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $3,503.81. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 15, 2024.

Amerisourcebergen Drug Corp is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:02 AM